Drug
Tegafur-gimeracil-oteracil clinical trials
- studies test it
- 18
- open now
- 5
- in phase 3
- 5
- first study started
- 2006
Keep track of what changes. Save the tegafur-gimeracil-oteracil studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
17 studies that test it; most in 2014 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 14
- Phase 3
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 17
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (2) · Shanghai Zhongshan Hospital (2) · Zhejiang Cancer Hospital (2) · Yu jiren (1) · Ono Pharmaceutical Co. Ltd (1) · University of Edinburgh (1) · AIO-Studien-gGmbH (1) · Dutch Colorectal Cancer Group (1)
Often tested with
Tested in the same studies.
Oxaliplatin (4) · Albumin-Bound Paclitaxel (3) · Paclitaxel (3) · Capecitabine (2) · Cisplatin (2) · Camrelizumab (1) · Bevacizumab (1) · Nivolumab (1)
Studies
Open first, then newest update. How each study uses tegafur-gimeracil-oteracil is read from its arms, and is right about nine times in ten.
Testing it · 18
- Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJRecruitingPhase 2Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT06808971Written as Adebrelimab, Nab-paclitaxel, Oxaliplatin, Tegafur Gimeracil Oteracil Potassium Capsule
- Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell CarcinomaRecruitingPhase 2Zhejiang Cancer HospitalNCT06422858Written as Tegafur-gimeracil-oteracil potassium capsule(S1)
- Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line TreatmentNot yet recruitingPhase 2/3Sun Yat-sen UniversityNCT06662877Written as Albumin-bound Paclitaxel + Tegafur Gimeracil Oteracil (S-1) + Anlotinib
- A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric CancerNot yet recruitingPhase 1Shanghai Zhongshan HospitalNCT05396326Written as Teysuno
- Neoadjuvant TACiE in Locally Advanced Gastric CancerNot yet recruitingPhase 2Shanghai Zhongshan HospitalNCT05346874Written as Teysuno
- Bevacizumab Plus Nab-paclitaxel and Tegafur Gimeracil Oteracil Potassium Capsule (S-1) as Second-line Treatment for Advanced Biliary Tract Cancer: a Phase Ⅱ Clinical TrialCompletedPhase 2Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT07719738Written as Bevacizumab+nab-paclitaxel+tegafur gimeracil oteracil potassium capsule (S-1)
- Adjuvant Chemotherapy in Combination With Camrelizumab for Stage III Gastric Cancer (FOCUS-02)Active, not recruitingPhase 2Yu jirenNCT04515615Written as Tegafur gimeracil oteracil potassium capsule
- Study of ONO-4538 in Gastric CancerCompletedPhase 2/3Ono Pharmaceutical Co. LtdNCT02746796Written as Tegafur- Gimeracil-Oteracil potassium
- Study to Compare Cardiovascular Side Effects of Teysuno Versus CapecitabineCompletedPhase 2University of EdinburghNCT01845337Written as Teysuno
- Tegio Consolidation Therapy for NPC Patients With High Risk of MetastasisStatus unknownPhase 2Zhejiang Cancer HospitalNCT03904225Written as Tegafur-Gimeracil-Oteracil
- Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric CancerCompletedPhase 2AIO-Studien-gGmbHNCT02128243Written as S-1 de-escalation
- A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck CancersStatus unknownPhase 2Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityNCT03096184Written as Tegafur Gimeracil Oteracil Potassium Capsules
- S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.CompletedPhase 3Dutch Colorectal Cancer GroupNCT01918852Written as Teysuno
- Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by SurgeryCompletedPhase 3Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanNCT00660894Written as tegafur-gimeracil-oteracil potassium
- A Study of TS-1, Cisplatin (CDDP) and RAD001 (Everolimus)TerminatedPhase 1National University Hospital, SingaporeNCT01096199Written as TS-ONE, Cisplatin, RAD001
- A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric CancerCompletedPhase 2National Cancer Centre, SingaporeNCT01736410Written as Trastuzumab, TS ONE, Cisplatin
- Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast CancerStatus unknownPhase 2Chinese Academy of Medical SciencesNCT01492543Written as Tegafur Gimeracil Oteracil Potassium Capsule
- Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric CarcinomaTerminatedPhase 2/3Eastern Network of Cancer Immunological Therapy, JapanNCT00503321Written as Tegafur/gimeracil/oteracil potassium (S-1)
Given in every arm · 16 — tegafur-gimeracil-oteracil is usual care beside what is tested
- A Single-Arm Study of QL1706 Combined With DOS as Neoadjuvant Therapy for Locally Advanced Gastric/GEJ AdenocarcinomaNot yet recruitingPhase 2The First Affiliated Hospital of Zhengzhou UniversityNCT07828873Written as Tegafur-Gimeracil-Oteracil
- A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal AdenocarcinomaNot yet recruitingPhase 3Ono Pharmaceutical Co., Ltd.NCT07818070Written as Tegafur-gimeracil-oteracil potassium (S-1)
- Cadonilimab Combination With Chemotherapy With or Without AK117 in Resectable Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingPhase 2AkesoNCT05960955Written as Tegafur-gimeracil-oteracil potassium
- Study of Comparing of With and Without Sequential Therapy of S-1RecruitingPhase 3Zhejiang UniversityNCT05813015Written as Tegafur-Gimeracil-Oteracil
- HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric JunctionNot yet recruitingPhase 2Xuefei.WangNCT05095467Written as Tegafur-gimeracil-oteracil potassium
- Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ AdenocarcinomaRecruitingPhase 3Fudan UniversityNCT04997837Written as Tegafur-gimeracil-oteracil potassium
- PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant ChemotherapyCompletedPhase 3Shanghai Cancer Hospital, ChinaNCT03013010Written as Tegafur-Gimeracil-Oteracil Potassium
- Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric CancerTerminatedPhase 2Fudan UniversityNCT05161572Written as Tegafur-Gimeracil-Oteracil
- Study of Adjuvant ONO-4538 With Resected Gastric CancerCompletedPhase 3Ono Pharmaceutical Co. LtdNCT03006705Written as Tegafur-gimeracil-oteracil potassium
- A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedPhase 2Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityNCT03267121Written as Tegafur Gimeracil Oteracil Potassium Capsules
- Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic CancerStatus unknownPhase 2National Taiwan University HospitalNCT04377048Written as Tegafur-Gimeracil-Oteracil
- Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic CancerTerminatedPhase 2Henan Cancer HospitalNCT03002831Written as Tegafur-Gimeracil-Oteracil Potassium
- S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic CancerStatus unknownPhase 2National Taiwan University HospitalNCT03316326Written as Tegafur-gimeracil-oteracil potassium
- Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSKCompletedPhase 3Hokuriku-Kinki Immunochemotherapy Study GroupNCT00216034Written as Tegafur-gimeracil-oteracil potassium (TS-1)
- Study of TS-1 or TS-1 + PSK for Gastric Cancer PatientsStatus unknownPhase 3Tokyo Metropolitan Oncology GroupNCT00687843Written as Tegafur-gimeracil-oteracil potassium (TS-1)
- Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric CancerStatus unknownPhase 2Yonsei UniversityNCT00985556Written as tegafur-gimeracil-oteracil potassium